In a landmark development for public healthcare in Central India, AIIMS Bhopal is set to formally launch its lung transplant programme on March 28, 2026 — making it the first and only government hospital in the region to offer heart, kidney, bone marrow, and lung transplants all under one roof, and entirely free of cost.

This is not merely a medical milestone — it is a transformational moment for millions of patients across Madhya Pradesh, Chhattisgarh, and neighbouring states who have long been forced to travel to distant metro cities and pay lakhs at private hospitals for life-saving organ transplants.

What Makes This Launch So Significant?

With the regulatory site inspection now complete and final government approval imminent, AIIMS Bhopal is days away from becoming the only government hospital in Central India to offer heart, kidney, bone marrow, and lung transplants — all under one roof and entirely free of cost for eligible patients.

AIIMS Bhopal's entry into lung transplants is the next step in a transplant programme that has been steadily expanding since 2024. In January 2025, the institute performed Madhya Pradesh's first successful heart transplant — a landmark procedure that demonstrated its capacity to handle the most complex organ transplant operations. To date, AIIMS Bhopal has completed 3 heart transplants and 17 kidney transplants, building a strong foundation of transplant expertise.

The regulatory process is nearly complete. The inspection team has examined the infrastructure, operation theatres, ICU capacity, post-transplant care protocols, and the qualifications of the surgical team. Minor deficiencies identified during the inspection have since been addressed, and the institute now awaits the final official permission before performing its first lung transplant procedure.

A Broader Infrastructure Overhaul Underway

The lung transplant launch is only one piece of a much larger transformation at AIIMS Bhopal. The institute is set to install Gamma Knife and PET Scan machines, strengthen organ transplant services, and build a new dedicated ICU block. Robotic surgery facilities are also being expanded, enabling patients to receive cutting-edge treatments without leaving Madhya Pradesh.

A dedicated transplant operation theatre — separate from general surgical OTs and designed specifically for the sterile, infection-controlled environment that organ transplants demand — is being commissioned this year. This will allow heart, liver, kidney, and lung transplants to be performed under optimal conditions, with reduced waiting times and improved infection management.

India's Transplant Expansion: Other States Catching Up

AIIMS Bhopal is part of a national wave of organ transplant expansion across India's government hospitals. Several AIIMS campuses and state medical institutions — including in Odisha, Rajasthan, Uttar Pradesh, and Puducherry — have either recently launched or significantly expanded their liver and organ transplant programmes under central government guidance.

Teams from leading transplant institutions have trained surgeons and medical staff at multiple public sector hospitals across the country, helping start and restart liver transplant programmes that had previously been unavailable outside major private hospitals in Delhi, Mumbai, and Chennai.

Yet the numbers reveal how much ground remains to be covered. Lung transplants are currently limited to just 11 states across India, while heart transplants are available in only 14 states — indicating that these procedures are still largely restricted to states with the most advanced healthcare infrastructure.

What This Means for Patients

The impact of AIIMS Bhopal's expansion is deeply human. When the institute performs its first lung transplant, it will mean that one of medicine's most complex and life-giving procedures is within reach of a farmer from Vidisha, a coal miner from Korba, or a textile worker from Indore — all of them equally entitled to the chance at a second life that a lung transplant represents.

India's organ transplant demand far outpaces supply:

• An estimated 2 lakh patients die of liver failure or liver cancer annually in India, a significant portion of whom could be saved with a timely transplant.
• Around 50,000 people suffer from end-stage heart failure every year, yet only a small fraction ever receive transplants.
• Deceased organ donation rates in India remain critically low, making awareness and system-building more urgent than ever.

The Road Ahead: Free Treatment, Greater Access

AIIMS Bhopal's model — offering all major transplants free of charge at a government institution — sets a precedent that other AIIMS campuses and state medical colleges are now looking to replicate. With leading institutions in Delhi, Bhubaneswar, and now Bhopal active in the transplant space, the architecture of accessible organ transplantation in India is being rebuilt from the ground up.

Healthcare Policy Perspective: "The expansion of transplant services to government hospitals is not just a medical achievement — it is a social justice imperative. Every life-saving surgery available in a private hospital in Delhi or Mumbai must eventually be accessible to a patient in Bhopal or Bilaspur."

The AIIMS Bhopal lung transplant launch on March 28, 2026 is a defining chapter in India's public healthcare story. As organ transplant services expand across Central India and beyond — from liver units in eastern states to lung programmes in Madhya Pradesh — the promise of equitable, world-class medical care for every Indian is slowly, meaningfully becoming real. For patients who once had nowhere to turn, the doors of hope are finally opening.